After nearly a decade of developing immersive patient experiences with leading pharmaceutical companies, A Life in a Day is calling attention to what it describes as the Patient Insight-to-Action Gap: the distance between understanding the patient experience and translating that understanding into measurable changes in behavior, decisions and outcomes.
LONDON, Nov. 17, 2026 /PRNewswire-PRWeb/ -- Developed with leading pharmaceutical companies, immersive patient experiences are helping teams turn patient understanding into measurable action
Pharmaceutical companies have more patient insight than ever before. But the industry's next challenge isn't gathering more insight, it's proving what changes because of it.
After nearly a decade of developing immersive patient experiences with leading pharmaceutical companies, A Life in a Day is calling attention to what it describes as the Patient Insight-to-Action Gap: the distance between understanding the patient experience and translating that understanding into measurable changes in behavior, decisions and outcomes.
Rather than simply providing teams with more patient research, stories or information, A Life in a Day's 24-hour immersive experiences allow participants to encounter elements of living with a condition as they go about their normal day and then connect what they experience directly to their individual roles and responsibilities.
Today, A Life in a Day is used by 16 of the world's top 20 pharmaceutical companies, with measurable results across commercial teams, clinical development and healthcare practice. Across its programs, 92% of participants implement patient-focused actions within 30 days.
Learn more about the Patient Insight-to-Action Gap and how pharmaceutical organizations are translating patient understanding into measurable action at https://alifeinaday.co.uk/the-patient-insight-to-action-gap/
"This wasn't a methodology we developed in isolation and then took to pharma," said Mark Doyle, founder & CEO of A Life in a Day. "It has evolved through years of working with pharmaceutical companies that wanted to solve a very real challenge: how do you take everything we're learning from patients and make it meaningful enough to change what people do? That's the gap we've been working to close."
From lived experience to measurable outcomes
The impact can be seen across different functions of the pharmaceutical organization.
In a program involving 1,300 commercial team members at a top-five global pharmaceutical company, 98% became more confident bringing the patient experience to life, 85% more effectively articulated the patient unmet need and patient type, and 31% of the team observed more time given by HCPs to complete their calls.
In a similar program within a global R&D team, participants identified 553 individual patient-focused actions, with the first action implemented within an average of 26 days. Changes made to clinical trial delivery after taking part were associated with increased patient retention, reduced trial costs and richer data.
The program has also demonstrated impact in healthcare practice. In a pilot partnership with senior medical professionals and the MS Society, 100% of participants reported increased empathy for patients, participants identified 25 opportunities for action, and first actions were implemented within an average of 22 days.
"Patient insight is incredibly valuable, but insight alone isn't the outcome," Doyle said. "The opportunity is to create an experience powerful enough that someone sees the patient's world differently and then asks what that means for the decisions they make in their own role."
As pharmaceutical organizations continue to invest in patient engagement and patient-informed decision-making, A Life in a Day believes the next evolution is to put greater emphasis on what happens after those insights are gathered.
The question is no longer only: "Are we listening to patients?" But: "What changed because we listened?"
About A Life in a Day
A Life in a Day works with pharmaceutical and healthcare organizations to create immersive patient experiences that translate patient understanding into measurable action. Developed through more than a decade of collaboration with leading pharmaceutical companies, its programs are used across commercial, clinical development, medical affairs, patient engagement and organizational learning, as well as by policymakers, journalists, healthcare professionals and other stakeholders who shape healthcare decision-making.
For more information, visit alifeinaday.co.
Media Contact
Alex Cull, A Life in a Day, 44 (0)204 570 0152, [email protected], alifeinaday.co
SOURCE A Life in a Day

Share this article